Cyclerion Therapeutics Inc (CYCN)
3.218
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
Cyclerion Therapeutics Total Assets (Quarterly): 13.37M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.37M |
| September 30, 2023 | 15.21M |
| June 30, 2023 | 10.10M |
| March 31, 2023 | 11.46M |
| December 31, 2022 | 18.08M |
| September 30, 2022 | 25.05M |
| June 30, 2022 | 35.21M |
| March 31, 2022 | 46.52M |
| December 31, 2021 | 59.33M |
| September 30, 2021 | 67.74M |
| June 30, 2021 | 75.73M |
| Date | Value |
|---|---|
| March 31, 2021 | 99.97M |
| December 31, 2020 | 115.38M |
| September 30, 2020 | 131.40M |
| June 30, 2020 | 128.04M |
| March 31, 2020 | 140.03M |
| December 31, 2019 | 186.48M |
| September 30, 2019 | 209.70M |
| June 30, 2019 | 235.50M |
| March 31, 2019 | 9.773M |
| December 31, 2018 | 7.401M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.10M
Minimum
Jun 2023
235.50M
Maximum
Jun 2019
85.49M
Average
67.74M
Median
Sep 2021
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| iBio Inc | 34.02M |
| AbbVie Inc | 134.71B |
| Agile Therapeutics Inc | 10.26M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.086M |
| Shareholders Equity (Quarterly) | 11.29M |